CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 30, 2012--
AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) today announced that the
company’s management will present a company overview at upcoming
investment conferences.
Tuan Ha-Ngoc, president and chief executive officer, is scheduled to
present at the Deutsche Bank 37th Annual Health Care
Conference on Tuesday, May 8, 2012 at 3:30 p.m. (ET) at the
InterContinental Hotel in Boston.
David Johnston, chief financial officer, is scheduled to present at the
2012 BofA Merrill Lynch Health Care Conference on Thursday, May 17, 2012
at 12:00 p.m. (PT) at Encore at the Wynn Las Vegas.
Webcasts of AVEO’s presentations can be accessed by visiting the
investors section of the company’s website at investor.aveopharma.com. A
replay of the webcasts will be archived on the AVEO website for two
weeks following each presentation date, respectively.
About AVEO
AVEO Pharmaceuticals (Nasdaq: AVEO) is a cancer therapeutics company
committed to discovering, developing and commercializing targeted
therapies to impact patients’ lives. AVEO’s proprietary Human Response
Platform™ provides the company unique insights into cancer biology and
is being leveraged in the discovery and clinical development of its
cancer therapeutics. For more information, please visit the company’s
website at www.aveopharma.com.
Source: AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc.
Investor Contact:
Monique
Allaire, 617-299-5810
or
Media Contact:
Rob
Kloppenburg, 617-299-5655
View printer-friendly version
